Clinical Trial Update: Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion update of a Phase 1/2 trial evaluating the combination of ruxolitinib and pomalidomide in patients with primary or secondar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Pomalidomide (Pomalidomide)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: University of Ulm | Conditions: Primary Myelofibrosis, Secondary Myelofibrosis | Phase 1, Phase 2 | Status: COMPLETED